uniscope. Publikationen der SGO Stiftung

Springer Nature
Springer Nature
ISSN: 26260581, 2626059X

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
journal names
uniscope. Publikationen der SGO Stiftung
Publications
139
Citations
117
h-index
5
Top-3 countries
Switzerland (98 publications)
Germany (30 publications)
Austria (6 publications)

Most cited in 5 years

Found 
from chars
Publications found: 5726
Creating New Cis-Regulatory Elements of HBD to Reactivate Delta-Globin
Chen L., Liu D., Hong W., Xu L., Cheng L., Luo Y., Xu H., Liang J., Fang J., Li X.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Overexpression of ABCA1 in Carotid Endothelium of Hyperlipidemic Rabbits Modulates Vascular Inflammation
Wacker B.K., Bi L., Saenz-Pipaon G., Sanford N., Regan A.Z., Lim N.S., Liu L., Kim F., Dichek D.A.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Evaluation of Purification Methods for Minimizing Transgene Expression Background During Viral Manufacturing
Bento R., Burr A., Teryek M., Parekkadan B.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Encapsulation of a Single-Stranded Form of DNA Impurities into the Capsid of a Recombinant Adeno-Associated Virus
Uchida K., Ito-Kudo E., Higashiyama K., Masumi-Koizumi K., Yusa K., Yuan Y.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations
Chaugule S., Constantinou C.K., John A.A., Micha D., Eekhoff M., Gravallese E., Gao G., Shim J.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Minimally Humanized Ezh2 Exon-18 Mouse Cell Lines Validate Preclinical CRISPR/Cas9 Approach to Treat Weaver Syndrome
Gibson W.T., Lengyell T.C., Korecki A.J., Janssen S.M., Adair B.A., Gamu D., Lorincz M.C., Simpson E.M.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Analysis of HIV-1-Based Lentiviral Vector Particle Composition by PacBio Long-Read Nucleic Acid Sequencing
Suleman S., Khalifa M.S., Fawaz S., Alhaque S., Chinea Y., Themis M.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy Program
Lomash R.M., Dehdashti J., Shchelochkov O.A., Chandler R.J., Li L., Manoli I., Sloan J.L., Terse P., Xu X., Saade D., Stan R., Brooks P.J., Lo D.C., Bönnemann C.G., Venditti C.P., et. al.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
AAV-Mediated Gene Transfer of WDR45 Corrects Neurological Deficits in the Mouse Model of Beta-Propeller Protein-Associated Neurodegeneration
Carisi M.C., Shamber C., Bishop M., Sangster M., Chandrachud U., Meyerink B., Pilaz L.J., Grishchuk Y.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Hum Gene Therapy Briefs March 2025
Philippidis A.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Prevalence of Neutralizing Antibodies to AAV2 and AAV9 in Individuals with Niemann-Pick Disease, Type C1
Mylvara A.V., Davidson C.D., Alexander D., Venditti C.P., Porter F.D.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
Central Nervous System-Targeted Gene Therapy for the Treatment of Neurocognitive Deficits in Mucopolysaccharidosis Type II Mice
Chen G., Zhan X., Gao X., Yi M., Liang H., Chen Y., Lin Q., Yang J., Hou S., Maegawa G., Zhang H.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease
Hinsch V.G., Boye S.L., Boye S.E.
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0
ESGCT Abstract Author Index
Q2
Mary Ann Liebert
Human Gene Therapy 2025 citations by CoLab: 0

Top-100

Citing journals

1
2
3
4
5
6
7
8
1
2
3
4
5
6
7
8

Citing publishers

5
10
15
20
25
30
35
40
45
5
10
15
20
25
30
35
40
45

Publishing organizations

5
10
15
20
25
30
35
40
5
10
15
20
25
30
35
40

Publishing organizations in 5 years

5
10
15
20
25
5
10
15
20
25

Publishing countries

10
20
30
40
50
60
70
80
90
100
Switzerland, 98, 70.5%
Germany, 30, 21.58%
Austria, 6, 4.32%
Sweden, 5, 3.6%
USA, 3, 2.16%
United Kingdom, 2, 1.44%
Canada, 2, 1.44%
Thailand, 2, 1.44%
Kenya, 1, 0.72%
Netherlands, 1, 0.72%
Rwanda, 1, 0.72%
10
20
30
40
50
60
70
80
90
100

Publishing countries in 5 years

5
10
15
20
25
30
35
40
45
Switzerland, 45, 67.16%
Germany, 13, 19.4%
Sweden, 5, 7.46%
USA, 2, 2.99%
Austria, 2, 2.99%
United Kingdom, 2, 2.99%
Canada, 2, 2.99%
Thailand, 2, 2.99%
Kenya, 1, 1.49%
Netherlands, 1, 1.49%
Rwanda, 1, 1.49%
5
10
15
20
25
30
35
40
45